Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

Dublin data center denial highlights growing challenges in green power and connectivity for AI expansion, says GlobalData

The recent denial of a Google Data Center at Grange Castle Business Park in Dublin highlights the growing challenges in powering and constructing new data facilities. As power hungry technologies such as artificial intelligence (AI) expand, there is an increasing need for sustainable power solutions and enhanced data connectivity. Balancing the demands of AI with […]
Read more

Volvo’s revised electrification goal sparks mixed influencer opinions on electric future, reveals GlobalData

AB Volvo, part of China’s Geely Holding, has become the focal point of discussion among influencers on social media platform “X”, following its decision to revise its ambitious 2030 electrification goal. The Swedish automaker, previously committed to selling only fully electric vehicles (EV) by the end of the decade, has adjusted its target to a […]
Read more

Su-30 MKI aircraft engines procurement to enhance India’s combat readiness, says GlobalData

India is strengthening its combat readiness with the procurement of 240 AL-31FP engines for its Su-30 MKI fighter jets in a INR2,600 billion (~$3.1 billion) deal. Locally manufactured by Hindustan Aeronautics Limited under a licensing agreement with Russia’s NPO Saturn, these engines will enhance operational capabilities, maintain low production costs, and address the technical and […]
Read more

Dupert offers new hope for advanced NSCLC patients as China’s first KRAS G12C Inhibitor, says GlobalData

GenFleet Therapeutics and Innovent Biologics have secured approval from China’s National Medical Products Administration (NMPA) for Dupert (fulzerasib), the country’s first KRAS G12C inhibitor for advanced non-small cell lung cancer (NSCLC) in adults who have undergone prior systemic therapy. This breakthrough therapy addresses a challenging mutation, offering a critical new treatment option for patients with […]
Read more

NZ fixed communication market set for modest growth, driven by fiber broadband expansion, reveals GlobalData

New Zealand’s (NZ) fixed communication services market is poised for a modest growth, with revenue expected to rise from $1.3 billion in 2024 to $1.4 billion by 2029. This growth is driven by increasing demand for fixed broadband, particularly fiber-to-the-home/business (FTTH/B) connections, while investments in fiber infrastructure continue to advance the country’s high-speed broadband capabilities, […]
Read more

Taiwan ambitious submarine program a vital deterrence measure against China, says GlobalData

Taiwan is reinforcing its defense posture against China with an $8.8 billion investment in its Indigenous Defense Submarine Program, which aims to induct eight new submarines into its naval fleet over the next decade. These advanced submarines, developed with key support from the US and other allies, will significantly enhance Taiwan’s underwater warfare capabilities amid […]
Read more

IASP World Congress highlights need for unified guidelines on opioid use in chronic pain, says GlobalData

At the recently held International Association for the Study of Pain (IASP) World Congress, a presentation during a topical workshop revealed significant discrepancies in clinical practice guidelines (CPGs) across countries for opioid use in chronic pain management. The inconsistencies raise concerns about the role of CPGs in the overprescription of opioids, potentially exacerbating the risk […]
Read more

UK VC funding hits $9 billion during January-July 2024, driven by big-ticket investments, finds GlobalData

UK-based startups raised $9 billion funding through 704 venture capital (VC) deals announced during January-July 2024, which is a 7.9% year-on-year (YoY) increase in funding value despite a 14.3% decline in deal volume. This reflects an improving appetite for big-ticket investments in promising startups, positioning the UK as a resilient market in the global venture […]
Read more

AI and cybersecurity take center stage in Q2 2024 company filings, reveals GlobalData

Technology, travel and tourism, and insurance business sentiment improves Packaging and retail hit by shifting preferences and rising costs Israel, Indonesia, the UK, and the US witness sentiment growth Global business sentiment witnessed a marginal improvement of 0.2% year-over-year (YoY) during the second quarter (Q2) of 2024. While technology, travel and tourism, and insurance sectors […]
Read more

VC funding in India startups soars to $6.3 billion during January-July 2024 despite global caution, finds GlobalData

India’s startup ecosystem saw a significant surge in venture capital (VC) funding during January-July 2024, with a total of 672 deals raising $6.3 billion. This represents a massive 42.1% year-on-year (YoY) increase in funding value, despite a modest 1.2% rise in deal volume. The spike in funding highlights investor confidence in India’s promising startups, even […]
Read more

Rising ADHD diagnoses in 7MM linked to standardized screening tools and guidelines, says GlobalData

The increase in attention-deficit/hyperactivity disorder (ADHD) diagnoses across the seven major markets (7MM*) is closely tied to the adoption of standardized screening tools and updated clinical guidelines. These developments, particularly in the US, have led to more accurate identification of ADHD cases, especially among adults, helping to address the disorder’s significant socioeconomic and mental health […]
Read more

Top 50 APAC listed firms report 0.8% revenue dip amid oil and gas struggles, China’s slow recovery, reveals GlobalData

China dominates the list with 26 companies BYD, Dai-ichi Life Holdings, and Toyota Motor gain over 20% in revenue Financial services sector tops the list with 13 companies The top 50 listed companies in the Asia-Pacific (APAC) region faced a slight 0.8% year-on-year (YoY) dip in aggregate revenue, totaling $6.9 trillion, in 2023. The downturn […]
Read more

rVSV-ZEBOV vaccine first real-world data support prophylactic use for future Ebola outbreaks, says GlobalData

The rVSV-ZEBOV vaccine has demonstrated real-world effectiveness of approximately 84% against Ebola virus disease, revealed a recent study carried out by researchers in Europe and the Democratic Republic of the Congo (DRC). This retrospective, test-negative study, which analyzed 618 individuals during the 2018-2020 Ebola virus epidemic in the DRC, supports the prophylactic use of rVSV-ZEBOV […]
Read more

China pharma firms eye stronghold in therapeutic cancer vaccines market, says GlobalData

Cancer vaccines represent a burgeoning field in oncology, with the potential to revolutionize cancer treatment. Earlier, approved cancer vaccines were prophylactic against cancer-causing viruses. However, recent advancements have shifted towards developing therapeutic cancer vaccines, which focus on identifying tumor-specific antigens to create innovative cancer immunotherapies. In this context, Chinese companies are actively positioning themselves to […]
Read more
1 … 53 54 55 56 57 … 209